Your browser doesn't support javascript.
loading
The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis.
Mackay, Tara M; Dijksterhuis, Willemieke P M; Latenstein, Anouk E J; van der Geest, Lydia G; Sprangers, Mirjam A G; van Eijck, Casper H J; Homs, Marjolein Y V; Luelmo, Saskia A C; Molenaar, I Quintus; van Santvoort, Hjalmar; Schreinemakers, Jennifer M J; Wilmink, Johanna W; Besselink, Marc G; van Laarhoven, Hanneke W; van Oijen, Martijn G H.
Afiliação
  • Mackay TM; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • Dijksterhuis WPM; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
  • Latenstein AEJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • van der Geest LG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.
  • Sprangers MAG; Department of Medical Psychology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • van Eijck CHJ; Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Homs MYV; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Molenaar IQ; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital, Utrecht, the Netherlands.
  • van Santvoort H; Department of Surgery, Regional Academic Cancer Center Utrecht, UMC Utrecht Cancer Center and St Antonius Hospital, Utrecht, the Netherlands.
  • Schreinemakers JMJ; Department of Surgery, Amphia Hospital, Breda, the Netherlands.
  • Wilmink JW; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • Besselink MG; Department of Surgery, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • van Laarhoven HW; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands.
  • van Oijen MGH; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Electronic address: m.g.vanoijen@amsterdamumc.nl.
HPB (Oxford) ; 24(4): 443-451, 2022 04.
Article em En | MEDLINE | ID: mdl-34635432
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias Duodenais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Neoplasias Duodenais Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article